1. Membrane Transporter/Ion Channel Cell Cycle/DNA Damage
  2. GLUT Disulfidptosis
  3. BAY-876

BAY-876, a chemical probe, is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth. In addition, BAY-876 can induce the formation of disulfide bonds in actin cytoskeletal proteins, leading to the occurrence of cellular disulfidptosis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 1799753-84-6

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 131 在庫あり
Solution
10 mM * 1 mL in DMSO USD 131 在庫あり
Solid
2 mg $96 在庫あり
5 mg $120 在庫あり
10 mg $180 在庫あり
25 mg $300 在庫あり
50 mg $450 在庫あり
100 mg $720 在庫あり
500 mg $2160 在庫あり
1 g $3456 在庫あり
5 g   お問い合わせ  
10 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 52 publication(s) in Google Scholar

Other Forms of BAY-876:

Top Publications Citing Use of Products

顧客検証

Flow Cytometry
Cell Proliferation/Viability Assay
IF

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Biomed Eng. 2025 Sep 2.  [Abstract]

    BLI reveals that BAY-876 (3.84 mg/kg; Intrathecally injected on days 3 and 7 post-xenograft) treatment decreases the incidence of MB metastasis in ONS76 intracisternal xenograft models. Images were taken 8 days post implantation.

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Biomed Eng. 2025 Sep 2.  [Abstract]

    BLI reveals that BAY-876 (3.84 mg/kg; Intrathecally injected on days 3 and 7 post-xenograft) treatment decreases the incidence of MB metastasis in DAOY intracisternal xenograft models. Images were taken 8 days post implantation.

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 19;15(1):9027.  [Abstract]

    Quantification of blood Ly6Chigh and Ly6Clow monocytes from CX3CR1GFP mice treated with vehicle (n = 4) or 4.5 mg/kg/day BAY-876 (oral) for 4 days.

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 19;15(1):9027.  [Abstract]

    Quantification of blood Ly6Chigh monocyte viability after a 4-day treatment with vehicle (n = 4) or 4.5 mg/kg/day BAY-876 (oral) (n = 5) in C57BL6/J mice.

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 19;15(1):9027.  [Abstract]

    Representative histograms (left) and quantitative results (right) show the difference in 2-NBDG signal in monocytes after 4 days of treatment with the vector (n=4) or 4.5 mg/kg/day BAY-876 (n=2).

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 19;15(1):9027.  [Abstract]

    Quantification of bone marrow hematopoietic progenitors after acute vehicle or BAY-876 (4.5 mg/kg/day, oral) treatment.

    BAY-876 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 19;15(1):9027.  [Abstract]

    BAY-876 (0-6 mg/kg/day, oral) reduces monocyte count in a dose-dependent manner.

    GLUT アイソフォーム固有の製品をすべて表示:

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    BAY-876, a chemical probe, is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth. In addition, BAY-876 can induce the formation of disulfide bonds in actin cytoskeletal proteins, leading to the occurrence of cellular disulfidptosis[1][2][3].

    IC50 & Target[1]

    GLUT1

    2 nM (IC50)

    GLUT2

    10.08 μM (IC50)

    GLUT3

    1.67 μM (IC50)

    GLUT4

    0.29 μM (IC50)

    Cellular Effect
    Cell Line Type Value Description References
    DLD-1 IC50
    4809 nM
    Compound: 6; BAY-876
    Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assay
    Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assay
    [PMID: 32282207]
    DLD-1 IC50
    50 nM
    Compound: 6; BAY-876
    Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assay
    Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assay
    [PMID: 32282207]
    HEK293 IC50
    >10 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT3, SLC2A3) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A3 WT-OE cells
    Inhibition of the Glucose Transporter (GLUT3, SLC2A3) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A3 WT-OE cells
    10.5281/zenodo.7360656
    HEK293 IC50
    >10 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT2, SLC2A2) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A2 WT-OE cells
    Inhibition of the Glucose Transporter (GLUT2, SLC2A2) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A2 WT-OE cells
    10.5281/zenodo.7360664
    HEK293 IC50
    >10 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT3, SLC2A3) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A3 WT-OE cells (PubChem AID: 1794827)
    Inhibition of the Glucose Transporter (GLUT3, SLC2A3) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A3 WT-OE cells (PubChem AID: 1794827)
    10.5281/zenodo.7360656
    HEK293 IC50
    >10 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT2, SLC2A2) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A2 WT-OE cells (PubChem AID: 1794829)
    Inhibition of the Glucose Transporter (GLUT2, SLC2A2) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A2 WT-OE cells (PubChem AID: 1794829)
    10.5281/zenodo.7360664
    HEK293 IC50
    0.24 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT1, SLC2A1) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A1 WT-OE cells
    Inhibition of the Glucose Transporter (GLUT1, SLC2A1) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A1 WT-OE cells
    10.5281/zenodo.7360676
    HEK293 IC50
    0.24 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT1, SLC2A1) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A1 WT-OE cells (PubChem AID: 1794830
    Inhibition of the Glucose Transporter (GLUT1, SLC2A1) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A1 WT-OE cells (PubChem AID: 1794830
    10.5281/zenodo.7360676
    HEK293 IC50
    5.5 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT4, SLC2A4) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A4 WT-OE cells
    Inhibition of the Glucose Transporter (GLUT4, SLC2A4) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A4 WT-OE cells
    10.5281/zenodo.7360638
    HEK293 IC50
    5.5 μM
    Compound: 118191391
    Inhibition of the Glucose Transporter (GLUT4, SLC2A4) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A4 WT-OE cells (PubChem AID: 1794828)
    Inhibition of the Glucose Transporter (GLUT4, SLC2A4) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A4 WT-OE cells (PubChem AID: 1794828)
    10.5281/zenodo.7360638
    HEY IC50
    1002 nM
    Compound: Chemical probe: BAY-876
    Antiproliferative activity against human HEY cells assessed as reduction in cell viability after 72 hrs MTT assay
    Antiproliferative activity against human HEY cells assessed as reduction in cell viability after 72 hrs MTT assay
    [PMID: 30602670]
    OVCAR-3 IC50
    60 nM
    Compound: Chemical probe: BAY-876
    Antiproliferative activity against human OVCAR-3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    Antiproliferative activity against human OVCAR-3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
    [PMID: 30602670]
    SK-OV-3 IC50
    188 nM
    Compound: Chemical probe: BAY-876
    Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell viability after 72 hrs MTT assay
    Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell viability after 72 hrs MTT assay
    [PMID: 30602670]
    体外実験

    BAY-876 (25-75 nM; 24 and 72 hours) has the growth-inhibitory effect and leads to a dose-dependent decrease in numbers of SKOV-3 and OVCAR-3 cells[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Proliferation Assay[2]

    Cell Line: SKOV-3 and OVCAR-3 cells
    Concentration: 25, 50, 75 nM
    Incubation Time: 24 and 72 hours
    Result: Led to a dose-dependent decrease in numbers of SKOV-3 and OVCAR-3 cells.
    体内実験

    BAY-876 (oral administration; 1.5-4.5 mg/kg/day for 28 days) causes a clear dose-dependent inhibition of tumorigenicity in mice[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female NOD-scid IL2rgnull (NSG) mice carrying SKOV-3 subcutaneous (s.c.) xenografts[2]
    Dosage: 1.5, 3, 4.5 mg/kg
    Administration: Oral administration; daily; for 28 days
    Result: Caused a clear dose-dependent inhibition of tumorigenicity.
    分子量

    496.42

    分子式

    C24H16F4N6O2

    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C(C1=NC2=CC(F)=CC=C2C(C(NC3=C(C)N(CC4=CC=C(C#N)C=C4)N=C3C(F)(F)F)=O)=C1)N

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : ≥ 100 mg/mL (201.44 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.0144 mL 10.0721 mL 20.1442 mL
    5 mM 0.4029 mL 2.0144 mL 4.0288 mL
    10 mM 0.2014 mL 1.0072 mL 2.0144 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.5 mg/mL (5.04 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.67%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.0144 mL 10.0721 mL 20.1442 mL 50.3606 mL
    5 mM 0.4029 mL 2.0144 mL 4.0288 mL 10.0721 mL
    10 mM 0.2014 mL 1.0072 mL 2.0144 mL 5.0361 mL
    15 mM 0.1343 mL 0.6715 mL 1.3429 mL 3.3574 mL
    20 mM 0.1007 mL 0.5036 mL 1.0072 mL 2.5180 mL
    25 mM 0.0806 mL 0.4029 mL 0.8058 mL 2.0144 mL
    30 mM 0.0671 mL 0.3357 mL 0.6715 mL 1.6787 mL
    40 mM 0.0504 mL 0.2518 mL 0.5036 mL 1.2590 mL
    50 mM 0.0403 mL 0.2014 mL 0.4029 mL 1.0072 mL
    60 mM 0.0336 mL 0.1679 mL 0.3357 mL 0.8393 mL
    80 mM 0.0252 mL 0.1259 mL 0.2518 mL 0.6295 mL
    100 mM 0.0201 mL 0.1007 mL 0.2014 mL 0.5036 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    BAY-876
    製品番号:
    HY-100017
    数量:
    MCE 日本正規代理店: